MLH1 and endometrial cancer: Methylation of the MLH1 promoter is the most common cause of MMRd and microsatellite instability (MSI) in both colorectal cancer and endometrial cancer and is routinely evaluated in tumors that show loss of MLH1 and PMS2 by IHC (41, 43, 44).